Key result
Pretreatment with melatonin and agomelatine significantly mitigated adriamycin-induced nephrotoxicity in rats, improving 99mTc DMSA uptake and reducing blood urea nitrogen and creatinine levels.
Why the study?
The study aimed to determine the possible protective effects of melatonin and agomelatine against adriamycin nephrotoxicity using 99mTc DMSA renal scintigraphy and biochemical methods.
Does melatonin and/or agomelatine prevent adriamycin-induced nephrotoxicity in a rat model?
Does melatonin and/or agomelatine prevent adriamycin-induced nephrotoxicity in a rat model?
Melatonin and agomelatine demonstrate protective effects against adriamycin-induced nephrotoxicity in a rat model, as assessed by biochemical and scintigraphic markers.
Answers are grounded in this paper and cite their sources.
Supports renoprotection in rat model; hypothesis-generating, should not change practice.
OBJECTIVE: We aimed to determine the possible protective effects of melatonin and agomelatine on an animal model of adriamycin nephrotoxicity by 99mTc DMSA renal scintigraphy and biochemical methods. METHODS: Ten weeks old 49 male Wistar rats were randomly separated into seven groups; namely control (CON), adriamycin (ADR), melatonin (MEL), agomelatine (AGO), melatonin + adriamycin (MEL+ADR), agomelatine + adriamycin (AGO+ADR) and melatonin + agomelatine + adriamycin (MEL+AGO+ADR) groups. Nephrotoxicity was induced by a three-dose of 18 mg/kg adriamycin, i.p. at a 24 h interval on the 5th, 6th and 7th days. A dose of melatonin and agomelatine (40 mg/kg/i.p, the same doses) were injected for 7 days before and after the injected of ADR (18 mg/kg, i.p.), respectively. On the 8th day of the experiment, all animals were evaluated and scintigraphic and biochemical parameters were assessed, respectively. RESULTS: ADR significantly increased blood urea nitrogen (1040 %) and plasma creatinine (1020 %), and decreased 99mTc DMSA uptake levels (59 %) compared to the control (p < 0.001). Pretreatment with MEL, AGO, MEL+AGO mitigated these abnormalities produced by ADR in the kidney (p < 0.001). CONCLUSION: 99mTc DMSA for the early determination of ADR-induced nephrotoxicity had an important role. Also, a significant correlation was found between biochemical and scintigraphy parameters. Adriamycin caused significant damages to kidneys that were reduced with MEL and AGO (Tab. 2, Fig. 3, Ref. 39).
No takes yet. Share an insight, caveat, or question.
Aygün et al. (2019) studied Adriamycin-induced nephrotoxicity (n=49). Melatonin and agomelatine vs. Adriamycin alone was evaluated on 99mTc DMSA uptake levels (cpm) (p=<0.001). Pretreatment with melatonin and agomelatine significantly mitigated adriamycin-induced nephrotoxicity in rats, improving 99mTc DMSA uptake and reducing blood urea nitrogen and creatinine levels.
Synapse has enriched 10 related papers. Consider them for comparative context: